Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2003
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355899A1 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
10/29/2003EP1355893A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/29/2003EP1355890A1 1, 2, 4-oxadiazole derivatives as hppar alpha agonists
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355877A1 Process of obtaining compositions of stable lutein and lutein derivatives
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355668A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355664A2 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
10/29/2003EP1355659A2 Use of compositions containing pdgf-bb for promoting angiogenesis
10/29/2003EP1355652A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
10/29/2003EP1355649A2 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
10/29/2003EP1355647A2 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355644A2 The use of substituted azetidinone compounds for the treatment of sitosterolemia
10/29/2003EP1355641A2 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
10/29/2003EP1355638A2 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
10/29/2003EP1355635A1 New film coating
10/29/2003EP1355632A1 Amlodipine free base
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1257527B1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
10/29/2003EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003EP1147112B1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP0970095B1 Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003EP0831822B1 The use of calcium channel antagonists for treating cardiac, renal and gastrointestinal disorders and hypertension
10/29/2003EP0546118B1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
10/29/2003CN1452624A Hydropyridine deriv. acid addition salts
10/29/2003CN1452622A Piperzine devivs.
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452617A Acid-sensitive compounds, preparation and uses thereof
10/29/2003CN1452613A Amorphous torasemide modification
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452490A Composition and method for intervening neuronal death using sulfasalazine
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451745A Natto kinase produced using Bacillus subtilis, and producing method and use thereof
10/29/2003CN1451665A Carboxylic derivs. of diosgenin and process for preparing same
10/29/2003CN1451656A Novel salt of perindopril and pharmaceutical composition contg. same
10/29/2003CN1451427A Hypotensive and hypolipemic tea
10/29/2003CN1451419A Chinese medicine composition for treating pile
10/29/2003CN1451408A Chinese medicinal herb extract and use thereof
10/29/2003CN1451402A Chinese medicinal preparation for treating cadiovascular and cerebrovascular diseases
10/29/2003CN1451397A Guava leaf tea and producing method thereof
10/29/2003CN1451390A Medicine use of cyclodextrin derivs. and medicine composition thereof
10/29/2003CN1451384A Use of timosaponin for preparing medicine for preventing and treating brain apoplexy
10/29/2003CN1125818C Amino acid derivatives of substituted quinexaline 2,3-dione derivatives as glutamate receptor antagonists
10/29/2003CN1125647C Fumigation washing matter for treating anal diseases
10/29/2003CN1125646C Solid beverage for prevention and control of essential hypertension and productive method thereof
10/29/2003CN1125637C Application of 5,3',5'-trihydroxy-7-methoxyl dihydroflavone in preparing medicine
10/29/2003CN1125602C Beverage for altitude anoxia
10/29/2003CN1125601C Powdered prolycopene preparation, mfg. method thereof and use of same
10/28/2003US6639111 Bind on EP4 subtype receptor selectively and binds on the other subtype receptors weakly; side-effect reduction; autoimmune diseases; asthma; bone disorders; degenerative nerve diseases; sleeping disorders; anticoagulants
10/28/2003US6639078 Assays for ligands for nuclear receptors
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638976 3-benzoylphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders
10/28/2003US6638969 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638962 Cycloheptene compounds
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638916 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
10/28/2003US6638907 Laminin 8 and methods for its use
10/28/2003US6638767 Methods for delivering compounds into a cell
10/28/2003US6638727 Intraductally administering an estrogen activity modulator
10/28/2003US6638516 Strain selection of pneumococcal surface proteins
10/28/2003US6638499 A nitrogen group containing linkage which is attached one end with a polyoxyalkylene glycol polymer and other end is coupled with a drug; useful for drug delivery
10/28/2003CA2283939C Non-antigenic branched polymer conjugates
10/28/2003CA2253796C Inhibition of matrix metalloproteases by acetylene containing compounds
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/28/2003CA2221114C Atherosclerosis treatment
10/23/2003WO2003087383A1 Compositions for delivering enyzmes involved in amino acid metabolism using recombinant ademo-associated virus virons (raav virons), and method and use for treating aminoi acid metabolic disorders using such raav virons
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087364A1 Novel g protein-coupled receptor and its gene
10/23/2003WO2003087344A1 New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the preparation methods thereof
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087296A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087096A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003087091A1 Novel crystal of quinoxalinedione derivative anhydride
10/23/2003WO2003087088A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087086A2 Substituted indoles
1 ... 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 ... 1595